The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
VNDA · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
AXSM · Healthcare · No moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
| Measure | VNDA | ICCC | HROW | AXSM |
|---|---|---|---|---|
| Moat Score (0–100) | 34 (highest) | 34 (highest) | 34 (highest) | 34 (highest) |
| Methodology version | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 | moat-index@2.0.0 |
| Business trend | 56 | 58 | 59 (highest) | 57 |
| Pricing power | — | 54 | 87 (highest) | — |
| Returns on capital | 0 (highest) | 0 (highest) | 0 (highest) | 0 (highest) |
| Balance-sheet safety | 55 (highest) | 42 | 0 | 55 (highest) |
| Capital discipline | 24 (highest) | 16 | 24 (highest) | 24 (highest) |
| Price vs. high estimate | 451% above high estimate | No price data | No price data | No price data |
| Market cap | $314.4M | $100.9M | $1.7B | $11.3B |
| Moat tier | No moat | No moat | No moat | No moat |
| Filings as of | FY2025 | FY2025 | FY2025 | FY2025 |